Marker Therapeutics (FRA:GX1) Cash from Discontinued Operating Activities : €-0.06 Mil (TTM As of Sep. 2024)

View and export this data going back to . Start your Free Trial

What is Marker Therapeutics Cash from Discontinued Operating Activities?

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Marker Therapeutics's Cash from Discontinued Operating Activities for the three months ended in Sep. 2024 was €0.00 Mil. It means Marker Therapeutics received €0.00 Mil from discontinued investing activities. Marker Therapeutics's Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.06 Mil.

Marker Therapeutics Cash from Discontinued Operating Activities Historical Data

The historical data trend for Marker Therapeutics's Cash from Discontinued Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marker Therapeutics Cash from Discontinued Operating Activities Chart

Marker Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash from Discontinued Operating Activities

Get a 7-Day Free Trial

-5.15

-5.59

Marker Therapeutics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Cash from Discontinued Operating Activities	Get a 7-Day Free Trial															-0.24	-0.06	-	-	-

Marker Therapeutics Cash from Discontinued Operating Activities Calculation

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.06 Mil.

Marker Therapeutics Cash from Discontinued Operating Activities Related Terms

Thank you for viewing the detailed overview of Marker Therapeutics's Cash from Discontinued Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Marker Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marker Therapeutics Inc (FRA:GX1) » Definitions » Cash from Discontinued Operating Activities

Comparable Companies

Traded in Other Exchanges

MRKR:USA

Address

9350 Kirby Drive, Suite 300, Houston, TX, USA, 77054

Website

http//www.markertherapeutics.com

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.

Marker Therapeutics Headlines

No Headlines